Mark Pressprich

Mark Pressprich practices at Michigan Institute of Urology in Saint Clair Shores, Michigan.

Mark Pressprich's NPI, 1194288944, was assigned on April 9, 2019. Mark Pressprich graduated from Wayne State University School of Medicine in 2019. Mark Pressprich holds Michigan license 4301511048.

Mark Pressprich's primary practice is Michigan Institute of Urology, at 20952 12 Mile Rd, Saint Clair Shores, MI 48081 in Macomb County. The practice phone is (586) 771-4820.

Mark Pressprich's primary practice is Michigan Institute of Urology in Saint Clair Shores, Michigan. Mark Pressprich is also affiliated with Corewell Health William Beaumont University Hospital. The medical group on file is Michigan Institute of Urology. Dmand AI also links Mark Pressprich to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Mark Pressprich practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Mark Pressprich's primary specialty in the NPI Registry, under taxonomy code 208800000X. Mark Pressprich is licensed in Michigan.

CMS data shows 451 Medicare services from Mark Pressprich across 10 procedure codes in 2024, for 161 Medicare patients. Medicare paid $23,171 for them.

CMS counts 161 Medicare patients who saw Mark Pressprich in 2024. The largest group is 65 to 74, with 58 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.96, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Mark Pressprich's median patient age at 67, with 20% women.

In 2024, Mark Pressprich wrote 236 Medicare Part D claims for 124 patients. 91% of them were for generic drugs. CMS names the drug for 127 of them, across 6 drugs with 11 or more claims each, at $13,370 in total drug cost. In 2023, CMS named 125 claims across 6 drugs.

Mark Pressprich accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Prostate resection: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 3 papers to Mark Pressprich, published from 2011 to 2023. The most frequent topics are Prostatic Neoplasms. Mark Pressprich's most frequent co-author is Michael L. Cher, MD.

CMS Open Payments shows 132 general payments to Mark Pressprich from 30 drug and device companies from 2022 to 2025. Consulting fees make up the largest share, 55% of the total. Janssen Pharmaceuticals, Inc paid the most, $10,603.

Mark Pressprich graduated from Wayne State University School of Medicine in 2019.